|
※サムネイル画像をクリックすると拡大画像が表示されます。
Western Blot of Mouse Anti-AKT1 Antibody. Lane 1: Opal Prestained Molecular Weight Protein (p/n MB-210-0500). Lane 2: AKT1 protein (p/n 009-001-P21). Lane 3: AKT2 protein (p/n 009-001-P22). Lane 4: AKT3 protein (p/n 009-001-P23). Load: 50ng. Blocking: BlockOut Buffer (p/n MB-073) for 30 min at RT. Primary Antibody: Anti-AKT1 at 1ug/mL o/n at 4°C. Secondary Antibody: Rabbit Anti-Mouse IgG HRP (p/n 610-403-C46, Lot 20121) at 1:40,000 in MB-073 for 30 min at RT.
PAGE-MAP (microsphere affinity proteomics) of Mouse Anti-AKT1 Antibody. (Catalog Number: 200-301-I51, Lot Number: 29014). Antibody array western blot binding of gelfree size separated fractions of multiple lysates (solid lines) and shotgun mass spectroscopy identification (dashed lines) of the target band run in parallel correlate confirming the specificity of this antibody against AKT1. Data was provided by the Lund-Johansen lab of Oslo University Hospital. For more information on PAGE-MAP/IP-MS identification of antibody specificity and its large-scale implementation for antibody validation see Sikorski et. al., (2018) Nature Methods 15, 909-912.
Plate was coated with monoclonal anti AKT1 antibody (capture antibody) followed by incubation with recombinant AKT1 (p/n 009-001-P21), AKT2 (p/n 009-001-P22), AKT3 (p/n 009-001-P23) proteins. Binding was detected with biotinylated monoclonal anti-AKT pS473. The signal shows specificity of the monoclonal anti-AKT1 antibody to recombinant isoform AKT1 protein and not the isoform 2 and 3.
Western Blot of Mouse Anti-AKT1 antibody. Lane 1: AKT-1 Null. Lane 2: WT. Lane 3: MEF #1. Lane 4 : A549 (p/n W09-001-GX4). Lane 5: Calu-1. Lane 6: PC-3 (p/n W09-001-GV6). Lane 7: HepG2 (p/n W09-001-GJ5). Lane 8: Jurkat (p/n W09-001-370). Lane 9: SKOV3 (p/n W09-001-GX9). Lane 10: HEK293T (p/n W09-001-GX5). Lane 11: C2C12 (p/n W10-001-GL7). Load: 20 ug per lane. Primary antibody: AKT1 antibody at 1:1,000 for overnight at 4°C. Secondary antibody: Peroxidase mouse secondary antibody at 1:40,000 for 30 min at RT. Block: MB-070 for 30 min at RT. Predicted/Observed size: 56 kDa for AKT1. Note that phosphorylated AKT migrates slower and is observed in lanes 6 and 8 where AKT is constitutively activated in PC-3 and Jurkat cells.? Other band(s): none. Data provided by?Dr?Yuefeng?Tang, Dave Guertin Lab. U. Mass.
Western Blot of Mouse Anti-AKT1 antibody. Lane 1: GST Tagged recombinant AKT1. Lane 2: GST Tagged recombinant AKT2. Lane 3: GST Tagged recombinant AKT3. Load: 25 ng per lane. Primary antibody: AKT1 antibody at 1:1,000 for overnight at 4°C. Secondary antibody: Peroxidase mouse secondary antibody at 1:40,000 for 30 min at RT. Block: MB-070 for 30 min at RT. Predicted/Observed size: 78 kDa for AKT1. Other band(s): none.
|
|
|
Western Blot of Mouse Anti-AKT1 Antibody. Lane 1: Opal Prestained Molecular Weight Protein (p/n MB-210-0500). Lane 2: AKT1 protein (p/n 009-001-P21). Lane 3: AKT2 protein (p/n 009-001-P22). Lane 4: AKT3 protein (p/n 009-001-P23). Load: 50ng. Blocking: BlockOut Buffer (p/n MB-073) for 30 min at RT. Primary Antibody: Anti-AKT1 at 1ug/mL o/n at 4°C. Secondary Antibody: Rabbit Anti-Mouse IgG HRP (p/n 610-403-C46, Lot 20121) at 1:40,000 in MB-073 for 30 min at RT.
|
|
| 別品名 |
AKT 1 western blotting, AKT-1, PKB antibody, PKB gamma antibody, PKBGAMMA antibody, PRKBG antibody, Protein kinase Akt 1 antibody, Protein kinase B gamma antibody, RAC-gamma serine/threonine-protein kinase, RAC-PK-gamma, Chemiluminescent WB, Western Blotting Kit, Chemiluminescent Kit, Peroxidase Kit, Immunoblotting Kit
|
| 交差種 |
Human
|
| 適用 |
Western Blot Enzyme Linked Immunosorbent Assay Immuno Fluorescence
|
| 免疫動物 |
Mouse
|
| クローン |
14E5.A2.B2.H9
|
| 抗体クラス |
IgG2aκ
|
| 標識物 |
Unlabeled
|
| Accession No.(Gene/Protein) |
P31749
|
| Gene Symbol |
AKT1
|
| 参考文献 |
Madhunapantula SV, et al.The Akt signaling pathway: An emerging therapeutic target in malignant melanoma. Cancer Biol Ther. 2011 Dec 15;12(12) Gonzalez E, McGraw TE. The Akt kinases: isoform specificity in metabolism and cancer.Cell Cycle. 2009 Aug 15;8(16):2502-8 Madhunapantula SV, Robertson GP. The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma. Pigment Cell Melanoma Res. 2009 Aug;22(4):400-19.
|
|
| メーカー |
品番 |
包装 |
|
RKL
|
KCAI51
|
1 KIT
|
※表示価格について
|
※当社では商品情報の適切な管理に努めておりますが、表示される法規制情報は最新でない可能性があります。
また法規制情報の表示が無いものは、必ずしも法規制に非該当であることを示すものではありません。
商品のお届け前に最新の製品法規制情報をお求めの際はこちらへお問い合わせください。
|
※当社取り扱いの試薬・機器製品および受託サービス・創薬支援サービス(納品物、解析データ等)は、研究用としてのみ販売しております。
人や動物の医療用・臨床診断用・食品用としては、使用しないように、十分ご注意ください。
法規制欄に体外診断用医薬品と記載のものは除きます。
|
|
※リンク先での文献等のダウンロードに際しましては、掲載元の規約遵守をお願いします。
|
|
※CAS Registry Numbers have not been verified by CAS and may be inaccurate.
|